Gilead will begin charging U.S. patients for the experimental COVID-19 drug remdesivir in two weeks, the company and the government announced Monday, as cases surge and hospitalizations reach crisis levels … Click to Continue »
Read more here:: Gilead says it will charge $3,120 per patient for COVID-19 drug






